{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:46:30Z","timestamp":1788518790129,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Open Fund of the State Key Laboratory of Robotics and Systems","award":["SKLRS-2020-KF-07"],"award-info":[{"award-number":["SKLRS-2020-KF-07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07253-0","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:05:24Z","timestamp":1762167924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A novel palmitoylation-based molecular signature reveals COX6A1 as a key regulator in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Tianqi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-0970","authenticated-orcid":false,"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"1","key":"7253_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol Jan. 2018;15(1):11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109.","journal-title":"Nat Rev Gastroenterol Hepatol Jan"},{"issue":"10290","key":"7253_CR2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/s0140-6736(20)32511-3","volume":"5","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet (London England) Jun. 2021;5(10290):2212\u201324. https:\/\/doi.org\/10.1016\/s0140-6736(20)32511-3.","journal-title":"Lancet (London England) Jun"},{"issue":"11","key":"7253_CR3","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00125-024-06196-3","volume":"67","author":"EASL-EASD-EASO","year":"2024","unstructured":"EASL-EASD-EASO. Clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): executive summary. Diabetologia Nov. 2024;67(11):2375\u201392. https:\/\/doi.org\/10.1007\/s00125-024-06196-3.","journal-title":"Diabetologia Nov"},{"issue":"9","key":"7253_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol Sep. 2022;7(9):851\u201361. https:\/\/doi.org\/10.1016\/s2468-1253(22)00165-0.","journal-title":"Lancet Gastroenterol Hepatol Sep"},{"issue":"1","key":"7253_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cgh.2021.11.014","volume":"21","author":"JN Yong","year":"2023","unstructured":"Yong JN, Lim WH, Ng CH, et al. Outcomes of nonalcoholic steatohepatitis after liver transplantation: an updated Meta-Analysis and systematic review. Clinical Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association Jan. 2023;21(1):45\u2013e546. https:\/\/doi.org\/10.1016\/j.cgh.2021.11.014.","journal-title":"Clinical Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association Jan"},{"key":"7253_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.atherosclerosis.2022.07.010","volume":"355","author":"Z Wang","year":"2022","unstructured":"Wang Z, Ye M, Zhang XJ, et al. Impact of NAFLD and its pharmacotherapy on lipid profile and CVD. Atherosclerosis Aug. 2022;355:30\u201344. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.07.010.","journal-title":"Atherosclerosis Aug"},{"issue":"11","key":"7253_CR7","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1161\/circresaha.121.319059","volume":"28","author":"Z Chen","year":"2021","unstructured":"Chen Z, Liu J, Zhou F, et al. Nonalcoholic fatty liver disease: an emerging driver of cardiac arrhythmia. Circulation Research May. 2021;28(11):1747\u201365. https:\/\/doi.org\/10.1161\/circresaha.121.319059.","journal-title":"Circulation Research May"},{"key":"7253_CR8","doi-asserted-by":"publisher","unstructured":"Zhao YC, Zhao GJ, Chen Z, She ZG, Cai J, Li H. Nonalcoholic fatty liver disease: an emerging driver of hypertension. Hypertension (Dallas, Tex: 1979). Feb 2020;75(2):275\u2013284. https:\/\/doi.org\/10.1161\/hypertensionaha.119.13419","DOI":"10.1161\/hypertensionaha.119.13419"},{"issue":"8","key":"7253_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","volume":"18","author":"E Barreby","year":"2022","unstructured":"Barreby E, Chen P, Aouadi M. Macrophage functional diversity in NAFLD - more than inflammation. Nature Reviews Endocrinology Aug. 2022;18(8):461\u201372. https:\/\/doi.org\/10.1038\/s41574-022-00675-6.","journal-title":"Nature Reviews Endocrinology Aug"},{"issue":"7","key":"7253_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s12276-023-01027-8","volume":"55","author":"SZ Lin","year":"2023","unstructured":"Lin SZ, Wu WJ, Cheng YQ, et al. Prolyl endopeptidase remodels macrophage function as a novel transcriptional coregulator and inhibits fibrosis. Experimental & Mol Medicine Jul. 2023;55(7):1437\u201350. https:\/\/doi.org\/10.1038\/s12276-023-01027-8.","journal-title":"Experimental & Mol Medicine Jul"},{"issue":"6","key":"7253_CR11","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","volume":"79","author":"AL Hutchison","year":"2023","unstructured":"Hutchison AL, Tavaglione F, Romeo S, Charlton M. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance. J Hepatol Dec. 2023;79(6):1524\u201341. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.030.","journal-title":"J Hepatol Dec"},{"key":"7253_CR12","doi-asserted-by":"publisher","first-page":"101889","DOI":"10.1016\/j.molmet.2024.101889","volume":"81","author":"G Villano","year":"2024","unstructured":"Villano G, Novo E, Turato C, et al. The protease activated receptor 2 - CCAAT\/enhancer-binding protein beta - SerpinB3 axis Inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis. Mol Metab Mar. 2024;81:101889. https:\/\/doi.org\/10.1016\/j.molmet.2024.101889.","journal-title":"Mol Metab Mar"},{"key":"7253_CR13","doi-asserted-by":"publisher","first-page":"101789","DOI":"10.1016\/j.molmet.2023.101789","volume":"76","author":"Z Bai","year":"2023","unstructured":"Bai Z, Yin W, Liu R, et al. PRDX1 Cys52Ser variant alleviates nonalcoholic steatohepatitis by reducing inflammation in mice. Mol Metab Oct. 2023;76:101789. https:\/\/doi.org\/10.1016\/j.molmet.2023.101789.","journal-title":"Mol Metab Oct"},{"issue":"1","key":"7253_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrm2084","volume":"8","author":"ME Linder","year":"2007","unstructured":"Linder ME, Deschenes RJ. Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol Jan. 2007;8(1):74\u201384. https:\/\/doi.org\/10.1038\/nrm2084.","journal-title":"Nat Rev Mol Cell Biol Jan"},{"key":"7253_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chemphyslip.2014.02.001","volume":"180","author":"S Blaskovic","year":"2014","unstructured":"Blaskovic S, Adibekian A, Blanc M, van der Goot GF. Mechanistic effects of protein palmitoylation and the cellular consequences thereof. Chemistry Phys Lipids May. 2014;180:44\u201352. https:\/\/doi.org\/10.1016\/j.chemphyslip.2014.02.001.","journal-title":"Chemistry Phys Lipids May"},{"key":"7253_CR16","doi-asserted-by":"publisher","unstructured":"Ko PJ, Dixon SJ. Protein palmitoylation and cancer. EMBO Reports Oct. 2018;19(10). https:\/\/doi.org\/10.15252\/embr.201846666.","DOI":"10.15252\/embr.201846666"},{"issue":"5716","key":"7253_CR17","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1126\/science.1105654","volume":"18","author":"O Rocks","year":"2005","unstructured":"Rocks O, Peyker A, Kahms M, et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science Mar. 2005;18(5716):1746\u201352. https:\/\/doi.org\/10.1126\/science.1105654.","journal-title":"Science Mar"},{"issue":"7672","key":"7253_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature23887","volume":"21","author":"S Chen","year":"2017","unstructured":"Chen S, Zhu B, Yin C, et al. Palmitoylation-dependent activation of MC1R prevents melanomagenesis. Nature Sep. 2017;21(7672):399\u2013403. https:\/\/doi.org\/10.1038\/nature23887.","journal-title":"Nature Sep"},{"issue":"1","key":"7253_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41467-019-08691-3","volume":"20","author":"S Chen","year":"2019","unstructured":"Chen S, Han C, Miao X, et al. Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads. Nat Commun Feb. 2019;20(1):877. https:\/\/doi.org\/10.1038\/s41467-019-08691-3.","journal-title":"Nat Commun Feb"},{"issue":"7","key":"7253_CR20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1158\/0008-5472.Can-22-2595","volume":"4","author":"Y Sun","year":"2023","unstructured":"Sun Y, Li X, Yin C, et al. AMPK phosphorylates ZDHHC13 to increase MC1R activity and suppress melanomagenesis. Cancer Res Apr. 2023;4(7):1062\u201373. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2595.","journal-title":"Cancer Res Apr"},{"issue":"7829","key":"7253_CR21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","volume":"586","author":"M Zhang","year":"2020","unstructured":"Zhang M, Zhou L, Xu Y, et al. A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis. Nature Oct. 2020;586(7829):434\u20139. https:\/\/doi.org\/10.1038\/s41586-020-2799-2.","journal-title":"Nature Oct"},{"issue":"3","key":"7253_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","volume":"69","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhang C, Luo X, et al. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. J Hepatol. 2018;69(3):705\u201317. https:\/\/doi.org\/10.1016\/j.jhep.2018.04.006.","journal-title":"J Hepatol"},{"key":"7253_CR23","doi-asserted-by":"publisher","unstructured":"Rada P, Gonz\u00e1lez-Rodr\u00edguez \u00c1, Garc\u00eda-Monz\u00f3n C, Valverde \u00c1M. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis. 2020\/09\/25 2020;11(9):802. https:\/\/doi.org\/10.1038\/s41419-020-03003-w","DOI":"10.1038\/s41419-020-03003-w"},{"issue":"28","key":"7253_CR24","doi-asserted-by":"publisher","first-page":"e2302130","DOI":"10.1002\/advs.202302130","volume":"10","author":"M Xu","year":"2023","unstructured":"Xu M, Tan J, Zhu L, et al. Palmitoyltransferase ZDHHC3 aggravates nonalcoholic steatohepatitis by targeting S-Palmitoylated IRHOM2. Adv Sci (Weinh) Oct. 2023;10(28):e2302130. https:\/\/doi.org\/10.1002\/advs.202302130.","journal-title":"Adv Sci (Weinh) Oct"},{"issue":"4","key":"7253_CR25","doi-asserted-by":"publisher","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","volume":"316","author":"MP Suppli","year":"2019","unstructured":"Suppli MP, Rigbolt KTG, Veidal SS, et al. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. Am J Physiol Gastrointest Liver Physiol. 2019;316(4):G462\u201372. https:\/\/doi.org\/10.1152\/ajpgi.00358.2018.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"7253_CR26","doi-asserted-by":"publisher","first-page":"12541","DOI":"10.1038\/s41598-019-48746-5","volume":"9","author":"SA Hoang","year":"2019","unstructured":"Hoang SA, Oseini A, Feaver RE, et al. Gene expression predicts histological severity and reveals distinct molecular profiles of nonalcoholic fatty liver disease. Sci Rep. 2019;9(1):12541. https:\/\/doi.org\/10.1038\/s41598-019-48746-5.","journal-title":"Sci Rep"},{"key":"7253_CR27","doi-asserted-by":"publisher","unstructured":"Govaere O, Cockell S, Tiniakos D, et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci Transl Med. 2020;12(572). https:\/\/doi.org\/10.1126\/scitranslmed.aba4448.","DOI":"10.1126\/scitranslmed.aba4448"},{"issue":"4","key":"7253_CR28","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jcmgh.2022.12.008","volume":"15","author":"T Chen","year":"2023","unstructured":"Chen T, Dalton G, Oh SH, et al. Hepatocyte smoothened activity controls susceptibility to insulin resistance and nonalcoholic fatty liver disease. Cell Mol Gastroenterol Hepatol. 2023;15(4):949\u201370. https:\/\/doi.org\/10.1016\/j.jcmgh.2022.12.008.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"7253_CR29","doi-asserted-by":"publisher","first-page":"lqaa078","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genom Bioinform. 2020;2(3):lqaa078. https:\/\/doi.org\/10.1093\/nargab\/lqaa078.","journal-title":"NAR Genom Bioinform"},{"issue":"5","key":"7253_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"7253_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"7253_CR32","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, et al. Machine learning-based integration develops an immune-derived LncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6.","journal-title":"Nat Commun"},{"issue":"1","key":"7253_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220. https:\/\/doi.org\/10.1186\/s13059-017-1349-1.","journal-title":"Genome Biol"},{"issue":"1","key":"7253_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"issue":"5","key":"7253_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"issue":"21","key":"7253_CR36","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, et al. TIMER: A web server for comprehensive analysis of Tumor-Infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307.","journal-title":"Cancer Res"},{"key":"7253_CR37","doi-asserted-by":"publisher","unstructured":"Thorsson V, Gibbs DL, Brown SD, et al. The immune landscape of cancer. Immunity. 2018;48(4). https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023.","DOI":"10.1016\/j.immuni.2018.03.023"},{"issue":"1","key":"7253_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer Immunogenomic analyses reveal Genotype-Immunophenotype relationships and predictors of response to checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"issue":"7783","key":"7253_CR39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori JR, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575(7783):512\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1631-3.","journal-title":"Nature"},{"issue":"1","key":"7253_CR40","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using cellchat. Nat Commun. 2021;12(1):1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"issue":"D1","key":"7253_CR41","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, et al. CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51(D1):D870\u20136. https:\/\/doi.org\/10.1093\/nar\/gkac947.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"7253_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/gut.2006.119180","volume":"57","author":"F Diaz","year":"2008","unstructured":"Diaz F, Garcia S, Hernandez D, et al. Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies. Gut Feb. 2008;57(2):232\u201342. https:\/\/doi.org\/10.1136\/gut.2006.119180.","journal-title":"Gut Feb"},{"issue":"3","key":"7253_CR43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ajhg.2014.07.013","volume":"4","author":"G Tamiya","year":"2014","unstructured":"Tamiya G, Makino S, Hayashi M, et al. A mutation of COX6A1 causes a recessive axonal or mixed form of Charcot-Marie-Tooth disease. American J Hum Genetics Sep. 2014;4(3):294\u2013300. https:\/\/doi.org\/10.1016\/j.ajhg.2014.07.013.","journal-title":"American J Hum Genetics Sep"},{"issue":"10","key":"7253_CR44","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1080\/15548627.2020.1851492","volume":"17","author":"P Luo","year":"2021","unstructured":"Luo P, Yan H, Du J, et al. PLK1 (polo like kinase 1)-dependent autophagy facilitates gefitinib-induced hepatotoxicity by degrading COX6A1 (cytochrome c oxidase subunit 6A1). Autophagy. 2021;17(10):3221\u201337. https:\/\/doi.org\/10.1080\/15548627.2020.1851492.","journal-title":"Autophagy"},{"issue":"1","key":"7253_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41392-023-01437-0","volume":"16","author":"B Ma","year":"2023","unstructured":"Ma B, Ju A, Zhang S, et al. Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease. Signal Transduct Target Ther Jun. 2023;16(1):229. https:\/\/doi.org\/10.1038\/s41392-023-01437-0.","journal-title":"Signal Transduct Target Ther Jun"},{"key":"7253_CR46","doi-asserted-by":"publisher","first-page":"1051076","DOI":"10.3389\/fendo.2022.1051076","volume":"13","author":"T Mao","year":"2022","unstructured":"Mao T, Yang R, Luo Y, He K. Crucial role of T cells in NAFLD-related disease: A review and prospect. Front Endocrinol. 2022;13:1051076. https:\/\/doi.org\/10.3389\/fendo.2022.1051076.","journal-title":"Front Endocrinol"},{"issue":"1","key":"7253_CR47","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40200-024-01428-0","volume":"23","author":"M Golshan-Tafti","year":"2024","unstructured":"Golshan-Tafti M, Bahrami R, Dastgheib SA, et al. Comprehensive data on the relationship between KCNJ11 polymorphisms and gestational diabetes mellitus predisposition: a meta-analysis. J Diabetes Metab Disord Jun. 2024;23(1):475\u201386. https:\/\/doi.org\/10.1007\/s40200-024-01428-0.","journal-title":"J Diabetes Metab Disord Jun"},{"issue":"6","key":"7253_CR48","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.14218\/jcth.2022.00239","volume":"28","author":"R Kumar","year":"2022","unstructured":"Kumar R, Prakash SS, Priyadarshi RN, Anand U. Sarcopenia in chronic liver disease: A metabolic perspective. Journal Clin Translational Hepatology Dec. 2022;28(6):1213\u201322. https:\/\/doi.org\/10.14218\/jcth.2022.00239.","journal-title":"Journal Clin Translational Hepatology Dec"},{"issue":"3","key":"7253_CR49","doi-asserted-by":"publisher","first-page":"428","DOI":"10.14218\/jcth.2020.00072","volume":"28","author":"A Shetty","year":"2021","unstructured":"Shetty A, Giron F, Divatia MK, Ahmad MI, Kodali S, Victor D. Nonalcoholic fatty liver disease after liver transplant. Journal Clin Translational Hepatology Jun. 2021;28(3):428\u201335. https:\/\/doi.org\/10.14218\/jcth.2020.00072.","journal-title":"Journal Clin Translational Hepatology Jun"},{"issue":"2","key":"7253_CR50","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s40200-024-01461-z","volume":"23","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Ahangarpour A, Aghaei M, Mohammadpour Fard R, Jalali Far MA, Sakhavarz T. A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis. J Diabetes Metab Disord Dec. 2024;23(2):1621\u201333. https:\/\/doi.org\/10.1007\/s40200-024-01461-z.","journal-title":"J Diabetes Metab Disord Dec"},{"issue":"15","key":"7253_CR51","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.7150\/ijbs.64046","volume":"17","author":"M Qu","year":"2021","unstructured":"Qu M, Zhou X, Wang X, Li H. Lipid-induced S-palmitoylation as a vital regulator of cell signaling and disease development. Int J Biol Sci. 2021;17(15):4223\u201337. https:\/\/doi.org\/10.7150\/ijbs.64046.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"7253_CR52","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/gutjnl-2023-330826","volume":"73","author":"L Bu","year":"2024","unstructured":"Bu L, Zhang Z, Chen J, et al. High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT. Gut. 2024;73(7):1156\u201368. https:\/\/doi.org\/10.1136\/gutjnl-2023-330826.","journal-title":"Gut"},{"key":"7253_CR53","doi-asserted-by":"publisher","unstructured":"Amorim R, Magalh\u00e3es CC, Borges F, Oliveira PJ, Teixeira J. From Non-Alcoholic fatty liver to hepatocellular carcinoma: a story of (mal)adapted mitochondria. Biology (Basel). Apr. 2023;14(4). https:\/\/doi.org\/10.3390\/biology12040595.","DOI":"10.3390\/biology12040595"},{"key":"7253_CR54","doi-asserted-by":"publisher","unstructured":"Zhao Y, Zhou Y, Wang D, et al. Mitochondrial dysfunction in metabolic dysfunction fatty liver disease (MAFLD). Int J Mol Sci Dec. 2023;15(24). https:\/\/doi.org\/10.3390\/ijms242417514.","DOI":"10.3390\/ijms242417514"},{"key":"7253_CR55","doi-asserted-by":"publisher","first-page":"1463187","DOI":"10.3389\/fphar.2024.1463187","volume":"15","author":"Y Deng","year":"2024","unstructured":"Deng Y, Dong Y, Zhang S, Feng Y. Targeting mitochondrial homeostasis in the treatment of non-alcoholic fatty liver disease: a review. Front Pharmacol. 2024;15:1463187. https:\/\/doi.org\/10.3389\/fphar.2024.1463187.","journal-title":"Front Pharmacol"},{"issue":"7","key":"7253_CR56","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4254\/wjh.v16.i7.973","volume":"27","author":"XL Wang","year":"2024","unstructured":"Wang XL, Yang M, Wang Y. Roles of transforming growth factor-\u03b2 signaling in liver disease. World J Hepatol Jul. 2024;27(7):973\u20139. https:\/\/doi.org\/10.4254\/wjh.v16.i7.973.","journal-title":"World J Hepatol Jul"},{"key":"7253_CR57","doi-asserted-by":"publisher","unstructured":"Kamata S, Honda A, Ishii I. Current clinical trial status and future prospects of PPAR-Targeted drugs for treating nonalcoholic fatty liver disease. Biomolecules Aug. 2023;18(8). https:\/\/doi.org\/10.3390\/biom13081264.","DOI":"10.3390\/biom13081264"},{"issue":"4","key":"7253_CR58","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jgg.2021.09.009","volume":"49","author":"S Lu","year":"2022","unstructured":"Lu S, Wang Y, Liu J. Tumor necrosis factor-\u03b1 signaling in nonalcoholic steatohepatitis and targeted therapies. J Genet Genomics. 2022;49(4):269\u201378. https:\/\/doi.org\/10.1016\/j.jgg.2021.09.009.","journal-title":"J Genet Genomics"},{"key":"7253_CR59","doi-asserted-by":"publisher","unstructured":"Lesner NP, Wang X, Chen Z, et al. Differential requirements for mitochondrial electron transport chain components in the adult murine liver. Elife. 2022;11doi. https:\/\/doi.org\/10.7554\/eLife.80919.","DOI":"10.7554\/eLife.80919"},{"issue":"12","key":"7253_CR60","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1074\/mcp.RA118.000961","volume":"17","author":"K Lee","year":"2018","unstructured":"Lee K, Haddad A, Osme A, et al. Hepatic mitochondrial defects in a nonalcoholic fatty liver disease mouse model are associated with increased degradation of oxidative phosphorylation subunits. Mol Cell Proteomics Dec. 2018;17(12):2371\u201386. https:\/\/doi.org\/10.1074\/mcp.RA118.000961.","journal-title":"Mol Cell Proteomics Dec"},{"issue":"11","key":"7253_CR61","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","volume":"35","author":"K Sawada","year":"2023","unstructured":"Sawada K, Chung H, Softic S, Moreno-Fernandez ME, Divanovic S. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metab. 2023;35(11):1852\u201371. https:\/\/doi.org\/10.1016\/j.cmet.2023.10.009.","journal-title":"Cell Metab"},{"key":"7253_CR62","doi-asserted-by":"publisher","unstructured":"Xu X, Li H, Lin H, et al. MIF-mediated crosstalk between THRSP\u2009+\u2009hepatocytes and CD74\u2009+\u2009lipid-associated macrophages in hepatic periportal zone drives MASH. Hepatology Jun. 2025;12. https:\/\/doi.org\/10.1097\/hep.0000000000001429.","DOI":"10.1097\/hep.0000000000001429"},{"key":"7253_CR63","doi-asserted-by":"publisher","first-page":"1346446","DOI":"10.3389\/fimmu.2024.1346446","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang Z, Zhang H, et al. The effects of cGAS-STING Inhibition in liver disease, kidney disease, and cellular senescence. Front Immunol. 2024;15:1346446. https:\/\/doi.org\/10.3389\/fimmu.2024.1346446.","journal-title":"Front Immunol"},{"issue":"4","key":"7253_CR64","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/hep.26226","volume":"58","author":"K Begriche","year":"2013","unstructured":"Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology Oct. 2013;58(4):1497\u2013507. https:\/\/doi.org\/10.1002\/hep.26226.","journal-title":"Hepatology Oct"},{"issue":"2","key":"7253_CR65","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","volume":"78","author":"B Fromenty","year":"2023","unstructured":"Fromenty B, Roden M. Mitochondrial alterations in fatty liver diseases. J Hepatol Feb. 2023;78(2):415\u201329. https:\/\/doi.org\/10.1016\/j.jhep.2022.09.020.","journal-title":"J Hepatol Feb"},{"key":"7253_CR66","doi-asserted-by":"publisher","first-page":"1613640","DOI":"10.3389\/fnut.2025.1613640","volume":"12","author":"J Bai","year":"2025","unstructured":"Bai J, Zhang L, He L, Zhou Y. Altered mitochondrial function: a clue therapeutic strategies between metabolic dysfunction-associated steatotic liver disease and chronic kidney disease? Front Nutr. 2025;12:1613640. https:\/\/doi.org\/10.3389\/fnut.2025.1613640.","journal-title":"Front Nutr"},{"key":"7253_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.12.041","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ma H, Zhang B, et al. Protein palmitoylation in hepatic diseases: functional insights and therapeutic strategies. J Adv Res. 2024. https:\/\/doi.org\/10.1016\/j.jare.2024.12.041.","journal-title":"J Adv Res"},{"key":"7253_CR68","doi-asserted-by":"publisher","unstructured":"Xu M, Tan J, Zhu L et al. Palmitoyltransferase ZDHHC3 aggravates nonalcoholic steatohepatitis by targeting s-palmitoylated IRHOM2. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2023;10(28):e2302130. https:\/\/doi.org\/10.1002\/advs.202302130","DOI":"10.1002\/advs.202302130"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07253-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:05:25Z","timestamp":1762167925000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07253-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7253"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07253-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal research received approval from the Animal Experimentation Ethics Committee at Harbin Medical University (2025-DWSYLLCZ-67). This study adhered to all local legislative and institutional guidelines during its conduct.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors affirm that this research was carried out with no commercial or financial affiliations that might be interpreted as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1212"}}